Familial Dysbetalipoproteinemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-01-22
Clinical Trial Update: Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia [Phase 4]
Phase 4 clinical trial update comparing evolocumab added to standard lipid-lowering therapy versus placebo on fasting and post-fat-load lipi…